Palladium Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$283K Buy
4,030
+826
+26% +$55.8K 0.01% 293
2021
Q4
$200K Buy
+3,204
New +$201K 0.01% 331
2021
Q3
Sell
-3,418
Closed -$205K 294
2021
Q2
$205K Hold
3,418
0.01% 279
2021
Q1
$208K Buy
+3,418
New +$189K 0.01% 274
2020
Q1
Sell
-5,254
Closed -$268K 252
2019
Q4
$268K Sell
5,254
-5,126
-49% -$247K 0.02% 234
2019
Q3
$485K Buy
10,380
+5,048
+95% +$241K 0.03% 191
2019
Q2
$265K Sell
5,332
-2,713
-34% -$128K 0.02% 236
2019
Q1
$342K Sell
8,045
-267
-3% -$11.8K 0.02% 213
2018
Q4
$341K Sell
8,312
-2,243
-21% -$96.2K 0.03% 208
2018
Q3
$493K Sell
10,555
-1,081
-9% -$49.4K 0.03% 200
2018
Q2
$507K Sell
11,636
-1,695
-13% -$79K 0.04% 194
2018
Q1
$612K Sell
13,331
-3,302
-20% -$160K 0.05% 182
2017
Q4
$841K Sell
16,633
-398
-2% -$21K 0.06% 162
2017
Q3
$885K Sell
17,031
-2,303
-12% -$112K 0.07% 159
2017
Q2
$947K Sell
19,334
-11,382
-37% -$528K 0.07% 153
2017
Q1
$1.45M Sell
30,716
-1,595
-5% -$76K 0.12% 124
2016
Q4
$1.55M Sell
32,311
-2,486
-7% -$114K 0.13% 119
2016
Q3
$1.38M Sell
34,797
-107,449
-76% -$4.04M 0.12% 129
2016
Q2
$5.05M Sell
142,246
-3,832
-3% -$149K 0.46% 64
2016
Q1
$5.72M Sell
146,078
-13,132
-8% -$491K 0.53% 59
2015
Q4
$6.84M Buy
159,210
+1,044
+0.7% +$45.9K 0.63% 49
2015
Q3
$6.65M Buy
158,166
+746
+0.5% +$34.9K 0.66% 50
2015
Q2
$7.86M Buy
157,420
+1,866
+1% +$88.4K 0.7% 43
2015
Q1
$7.01M Sell
155,554
-12,306
-7% -$553K 0.6% 58
2014
Q4
$8.09M Sell
167,860
-1,641
-1% -$78K 0.7% 47
2014
Q3
$8.12M Sell
169,501
-757
-0.4% -$36.8K 0.73% 46
2014
Q2
$8.43M Buy
170,258
+20,132
+13% +$942K 0.75% 44
2014
Q1
$7.07M Buy
150,126
+31,850
+27% +$1.46M 0.65% 48
2013
Q4
$5.68M Buy
118,276
+117,939
+34,997% +$5.29M 0.54% 60
2013
Q3
$14K Hold
337
﹤0.01% 459
2013
Q2
$14K Buy
+337
New +$12.4K ﹤0.01% 471

Other funds holding MET

Palladium Partners's MET Position: Q1 2022 in Review

Palladium Partners increased its MetLife (MET) stake by 26% in Q1 2022, buying an estimated $55.8K and bringing the position to 4,030 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #293.

Palladium Partners first reported a position in MET in Q2 2013 and has held it in 31 quarters since. The position peaked at $8.43M in Q2 2014. 1,224 funds tracked by Wall St. Rank hold MET as of Q1 2022.

  • Palladium Partners held 4,030 shares of MetLife worth $283K as of Q1 2022.
  • Palladium Partners bought 826 MetLife shares in Q1 2022, an estimated $55.8K.
  • MetLife made up 0.01% of Palladium Partners's portfolio in Q1 2022, its #293 holding.
  • Palladium Partners first reported a position in MetLife in Q2 2013 and has held it in 31 quarters since.
  • Palladium Partners's MetLife position peaked at $8.43M in Q2 2014.
  • 1,224 funds tracked by Wall St. Rank held MetLife as of Q1 2022.

Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.